Literature DB >> 9892334

Consistent reversible elevations of serum creatinine levels in severe hypothyroidism.

S H Kreisman1, J V Hennessey.   

Abstract

BACKGROUND: Changes in routine clinical chemical indicators of renal function in the hypothyroid state are not well characterized, and are infrequently discussed in standard internal medicine or subspeciality textbooks. PATIENTS AND METHODS: We evaluated 24 consecutive patients with iatrogenic hypothyroidism induced prior to radioiodine scanning for monitoring of thyroid carcinoma. Serum creatinine and thyroid function tests were measured prior to, during, and subsequent to the period of induced hypothyroidism.
RESULTS: Among 29 episodes with paired prior euthyroid and hypothyroid serum creatinine values, the hypothyroid value was greater in 26 (89.7%), and equal in 3 (10.3%), less in none; the mean hypothyroid value was significantly greater (103 vs 76 micromol/L [1.17 vs 0.87 mg/dL]) (P<.001). Among 36 episodes with paired hypothyroid and subsequent euthyroid serum creatinine values, the hypothyroid value was greater in 33 (91.7%), equal in 2 (5.6%), and less in 1 (2.8%); the mean hypothyroid value was again significantly greater (102 vs 75 pmol/L [1.15 vs 0.85 mg/dL]) (P<.001). There was no significant difference between prior and subsequent euthyroid serum creatinine values. Serum creatinine values above the stated normal range occurred in 6 of 36 hypothyroid episodes.
CONCLUSIONS: There is a consistent and reversible elevation of serum creatinine values in the hypothyroid state. Frankly abnormal serum creatinine levels will occur in some cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892334     DOI: 10.1001/archinte.159.1.79

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  44 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Hypothyroidism and associated acute renal failure.

Authors:  Bhushan Joshi; Daniel Jones; Andrew Rochford; Louise Giblin
Journal:  J R Soc Med       Date:  2009-05       Impact factor: 5.344

3.  Age and the thyrotropin response to hypothyroxinemia.

Authors:  Rebecca Over; Sonia Mannan; Hala Nsouli-Maktabi; Kenneth D Burman; Jacqueline Jonklaas
Journal:  J Clin Endocrinol Metab       Date:  2010-05-19       Impact factor: 5.958

Review 4.  Optimal differentiated thyroid cancer management in the elderly.

Authors:  Donald S A McLeod; Kelly Carruthers; Dev A S Kevat
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

5.  The effect of electrolyte balance on the voice in hemodialysis patients.

Authors:  Saime Sagiroglu; Adem Doganer
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-21       Impact factor: 2.503

Review 6.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

Review 7.  Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients.

Authors:  Carlos G Musso; Waldo H Belloso; Richard J Glassock
Journal:  World J Nephrol       Date:  2016-01-06

8.  Renal failure and acquired hypothyroidism.

Authors:  Genoveva del-Río Camacho; Leopoldo Tapia Ceballos; Beatriz Picazo Angelín; Juan Antonio Ruiz Moreno; María Luisa Hortas Nieto; Julio Romero González
Journal:  Pediatr Nephrol       Date:  2003-02-25       Impact factor: 3.714

9.  Postoperative myxoedema coma.

Authors:  Robert James; Jessie James; Amarjit Singh Vij; Kamaljeet Kaur Vij
Journal:  BMJ Case Rep       Date:  2014-02-13

Review 10.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.